Transcatheter Embolization and Occlusion Devices Market Growth, Trends and Industry Outlook 2026–2034
According to Fortune Business Insights, the global Transcatheter Embolization and Occlusion Devices Market was valued at USD 6.01 billion in 2025 and is projected to grow from USD 6.48 billion in 2026 to USD 11.84 billion by 2034, registering a CAGR of 7.82% during 2026–2034. Increasing adoption of minimally invasive procedures, rising prevalence of cardiovascular and neurovascular disorders, and growing demand for advanced interventional radiology treatments are supporting market expansion.
Transcatheter embolization and occlusion devices are increasingly used for vascular embolization, aneurysm treatment, tumor management, gastrointestinal bleeding control, and other complex interventions. Their ability to support targeted treatment while reducing surgical trauma and hospitalization time is contributing to wider adoption across healthcare facilities.
Transcatheter Embolization and Occlusion Devices Market Growth Drivers
Rising Demand for Minimally Invasive Procedures
The growing preference for minimally invasive cardiovascular, neurovascular, and oncology procedures is a major factor driving market growth. Catheter-based interventions can reduce surgical trauma, recovery periods, and hospital stays compared with certain conventional procedures. Healthcare systems are also investing in catheterization laboratories, interventional radiology infrastructure, advanced imaging systems, and precision-guided technologies to meet rising procedural demand.
Increasing Prevalence of Cardiovascular and Neurovascular Disorders
The increasing burden of aneurysms, vascular malformations, gastrointestinal bleeding, and other vascular conditions is creating demand for embolization and occlusion technologies. Advancements in microcatheters, embolic materials, and image-guided procedures are further supporting adoption by enabling physicians to target specific blood vessels with greater procedural control.
Transcatheter Embolization and Occlusion Devices Market Trends
Advancements in Embolization and Image-Guided Technologies
Manufacturers are developing next-generation detachable coils, bioactive embolization materials, precision-controlled occlusion devices, and advanced liquid embolic systems. AI-integrated imaging, 3D vascular mapping, and robotic-assisted catheter navigation are also emerging as important technological developments because they can improve treatment planning and embolization accuracy. Growing adoption of outpatient procedures is additionally encouraging demand for compact and flexible catheter-based devices.
For detailed market insights, visit: https://www.fortunebusinessinsights.com/transcatheter-embolization-and-occlusion-devices-market-117410
Transcatheter Embolization and Occlusion Devices Market Opportunities
Expansion of Interventional Oncology and Neurovascular Therapies
The expansion of interventional oncology and neurovascular treatments is creating new opportunities for device manufacturers. Embolization technologies are increasingly utilized in targeted tumor management, aneurysm treatment, arteriovenous malformation procedures, and other vascular interventions. Emerging healthcare markets are also investing in interventional radiology infrastructure, creating opportunities for companies offering advanced coils, liquid embolics, vascular plugs, and robotic-assisted systems.
Transcatheter Embolization and Occlusion Devices Market Segmentation
By Product
Based on product, the market is segmented into coil and non-coil devices. The coil segment accounted for approximately 61% of the market, making it the leading product category. Coil embolization devices are widely used in neurovascular interventions, aneurysm treatment, and peripheral vascular procedures because they provide controlled vascular occlusion. Manufacturers are developing detachable, bioactive, and hydrogel-coated coils to improve procedural effectiveness.
The non-coil segment accounted for approximately 39% of the market and includes liquid embolics, vascular plugs, microspheres, and polymer-based occlusion systems. Increasing adoption in oncology, trauma management, and peripheral vascular procedures is supporting segment development.
Transcatheter Embolization and Occlusion Devices Market Regional Analysis
North America
North America dominated the global market with a 38% share in 2025. Advanced healthcare infrastructure, strong healthcare spending, widespread availability of catheterization laboratories, and increasing adoption of minimally invasive procedures are supporting regional growth. The U.S. remains an important market due to its established interventional cardiology and radiology infrastructure.
Europe
Europe accounted for 27% of the global market. Strong healthcare infrastructure, demand for minimally invasive vascular interventions, and investments in advanced imaging and robotic-assisted catheter systems are supporting market development. Germany accounted for approximately 31% of the European market, while the U.K. represented around 20%.
Asia-Pacific
Asia-Pacific represented 25% of the global market. Rising healthcare expenditure, increasing cardiovascular disease prevalence, and expanding interventional radiology infrastructure are creating growth opportunities. Japan accounted for approximately 29% of the Asia-Pacific market, while China represented around 41% of the regional market.
List of Top Transcatheter Embolization and Occlusion Devices Companies
Key companies operating in the market include Boston Scientific Corporation, Terumo Corporation, Medtronic, DePuy Synthes, Stryker, Cordis, Abbott, Pfizer Inc., Sirtex SIR-Spheres Pty Ltd., and Nordion (Canada) Inc. Boston Scientific Corporation accounted for approximately 24% of the market, while Medtronic held around 20%.
Competition is focused on product innovation, advanced embolic materials, minimally invasive treatment technologies, imaging integration, and expansion across emerging healthcare markets.
Transcatheter Embolization and Occlusion Devices Market Challenges
High procedure costs and limited availability of skilled interventional specialists can restrict adoption, particularly in developing healthcare markets. Advanced imaging infrastructure, catheterization laboratories, specialized devices, and trained professionals can increase treatment expenses. Regulatory complexity and stringent product safety requirements also require manufacturers to invest substantially in clinical validation, quality assurance, and post-market surveillance.
Request Sample Report
Future Outlook
The global Transcatheter Embolization and Occlusion Devices Market is expected to maintain steady growth as healthcare providers increasingly adopt minimally invasive cardiovascular, neurovascular, and oncology procedures. Continued innovation in detachable coils, liquid embolics, AI-assisted imaging, robotic catheter navigation, and biodegradable embolization materials is expected to create additional opportunities. The market is projected to reach USD 11.84 billion by 2034, expanding at a 7.82% CAGR from 2026 to 2034.
Comments